SS
Surinder Suri
About Surinder Suri
Data last updated:
Surinder Suri is a Director at Les Reins Lifesciences Private Limited (since 2019). The company operates in Pharma. Les Reins Lifesciences Private Limited reported revenue of ₹3.88 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Aug 2019 | 2018 | ₹3.88 Cr (FY 2025) | Active |
Board colleagues of Surinder Suri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gurpreet Kaur | 08078558 | Les Reins Lifesciences Private Limited | Director |
| Manmohan Singh Mathru | 08865383 | Les Reins Lifesciences Private Limited | Director |
| Manoj Kumar Thapa | 08539856 | Les Reins Lifesciences Private Limited | Director |
| Prabhjeet Singh | 08539847 | Les Reins Lifesciences Private Limited | Director |
| Reena Suri | 08078557 | Les Reins Lifesciences Private Limited | Director |
| Sabina Thapa | 08078559 | Les Reins Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Surinder Suri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surinder Suri
Surinder Suri currently holds 1 directorship: Les Reins Lifesciences Private Limited (Director, since 19 Aug 2019, revenue ₹3.88 Cr (FY 2025)).
Surinder Suri was first appointed on 19 Aug 2019 as Director at Les Reins Lifesciences Private Limited.
The current boards of Surinder Suri's companies include Gurpreet Kaur (Les Reins Lifesciences Private Limited), Manmohan Singh Mathru (Les Reins Lifesciences Private Limited), Manoj Kumar Thapa (Les Reins Lifesciences Private Limited), Prabhjeet Singh (Les Reins Lifesciences Private Limited), Reena Suri (Les Reins Lifesciences Private Limited), Sabina Thapa (Les Reins Lifesciences Private Limited).